Abstract
Background
There are no guidelines about the selection of recurrent cervical cancer patients for salvage surgery.
Methods
Patients who developed recurrent or persistent cervical cancer in a previously irradiated field and were subsequently treated with salvage surgery (the surgery group) or palliative care alone (the palliative group) were identified. Patient characteristics, treatment-related complications, and survival were retrospectively compared between the two groups.
Results
A total of 79 patients (surgery group, n = 51; palliative group, n = 28) were identified. In the surgery group, no intraoperative complications or treatment-related deaths occurred. Eleven patients (21.6%) experienced severe postoperative complications. After a median follow-up period of 41.5 months, 23 patients (45.1%) had developed recurrent disease, predominantly at distant sites, and 19 patients (37.3%) had died of disease progression. The estimated 3-year progression-free survival (PFS) and overall survival rates of the surgery group were 50.4 and 56.5%, respectively. In the palliative group, all of the patients died of disease progression. Positive surgical margins and lymph node metastasis were found to be independent prognostic factors for PFS in the surgery group. Among the patients with no or one poor prognostic factor, the patients in the surgery group survived significantly longer than those in the palliative group. However, among the patients with 2 poor prognostic factors, the surgery group and palliative group displayed similar survival periods.
Conclusions
Salvage surgery is a curative treatment in recurrent or persistent cervical cancer patients. However, considering its high surgical complication rate, salvage surgery should only be offered to carefully selected patients.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Monk BJ, Tewari KS (2014) Evidence-based therapy for recurrent cervical cancer. J Clin Oncol 32:2687–2690
Brader KR, Morris M, Levenback C, Levy L, Lucas KR, Gershenson DM (1998) Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 16:1879–1884
Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ (2014) Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 370:734–743
Jones TK Jr, Levitt SH, King ER (1970) Retreatment of persistent and recurrent carcinoma of the cervix with irradiation. Radiology 95:167–174
Randall ME, Evans L, Greven KM, McCunniff AJ, Doline RM (1993) Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol 48:23–31
Mabuchi S, Takahashi R, Isohashi F, Yokoi T, Okazawa M, Sasano T, Maruoka S, Anzai M, Yoshioka Y, Ogawa K, Kimura T (2014) Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience. Int J Gynecol Cancer 24:141–148
Chiva LM, Lapuente F, González-Cortijo L, González-Martín A, Rojo A, García JF, Carballo N (2008) Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol 110:S60–S66
Berek JS, Howe C, Lagasse LD, Hacker NF (2005) Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 99:153–159
Höckel M (2008) Laterally extended endopelvic resection (LEER)–principles and practice. Gynecol Oncol 111:S13–S17
Friedell GH, Cesare F, Parsons L (1961) Surgical treatment of cancer of the cervix recurring after primary irradiation therapy. N Engl J Med 264:781–784
Boers A, Arts HJ, Klip H, Nijhuis ER, Pras E, Hollema H, Wisman GB, Nijman HW, Mourits MJ, Reyners AK, de Bock GH, Thomas G, van der Zee AG (2014) Radical surgery in patients with residual disease after (chemo)radiation for cervical cancer. Int J Gynecol Cancer 24:1276–1285
Maneo A, Landoni F, Cormio G, Colombo A, Mangioni C (1999) Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy. Int J Gynecol Cancer 9:295–301
Rutledge S, Carey MS, Prichard H, Allen HH, Kocha W, Kirk ME (1994) Conservative surgery for recurrent or persistent carcinoma of the cervix following irradiation: is exenteration always necessary? Gynecol Oncol 52:353–359
Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN (1994) Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol 55:29–35
Tavassoli FA, Stratton MR, eds. Tumours of the uterine cervix. (2002) WHO classification of tumours: pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; p. 259–289
Mabuchi S, Isohashi F, Maruoka S, Hisamatsu T, Takiuchi T, Yoshioka Y, Kimura T (2012) Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy. Arch Gynecol Obstet 286:179–185
Mabuchi S, Isohashi F, Yoshioka Y, Temma K, Takeda T, Yamamoto T, Enomoto T, Morishige K, Inoue T, Kimura T (2010) Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy. Int J Gynecol Cancer 20:834–840
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Mabuchi, S., Matsumoto, Y., Komura, N. et al. The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience. Int J Clin Oncol 22, 927–936 (2017). https://doi.org/10.1007/s10147-017-1134-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-017-1134-x